PsyLabs

About PsyLabs

PsyLabs is an international supplier of pharmaceutical-grade psychoactive compounds, operating legal psychedelic cultivation and extraction facilities in Southern Africa. The company exports raw materials and extracts to research partners, customers, and a Contract Development & Manufacturing Organisation (CDMO) in the UK, focusing on developing standardized psychedelic drug substances and Active Pharmaceutical Ingredients (APIs) for research, clinical trials, and drug development through proprietary extraction methodologies.

Products & Services

Pharmaceutical Grade Psychedelic Compounds:Standardized psychedelic drug substances and APIs developed using proprietary extraction methods, supported by regulatory dossiers for clinical trials and drug development.

Psilocybin and Other Psychedelic Compounds:Federally licensed cultivation and export of psilocybin mushrooms, psilocin, mescaline, ibogaine, and DMT for legal medical and research markets.

GoodMind Functional Mushroom Wellness Products:A range of non-psychoactive, adaptogenic mushroom products for stress relief and general wellness benefits.

Specialties

Psychedelic Cultivation and Extraction Pharmaceutical Grade Psychoactive Compounds Active Pharmaceutical Ingredient (API) Development Regulatory Compliance and Support Proprietary Extraction Methodologies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Follow-on Investment T: - FT: Follow-on Investment	A: 3500000 MR: - FA: USD $3,500,000 FAN: 3500000	D: 2025-11-03 FD: 2025-11-03	1 investors

Follow-on Investment Latest

2025-11-03

$3.5M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tony

Recent News

PsyLabs Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised